The FDA will have 60 days “to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.
The program is aimed at meeting the rising demand for training and treatment in MDMA therapy.
California stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on ‘magic mushrooms,’ even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
My psychedelic MDMA experience put me into a hole of paranoia and dysregulation. Here’s what it took for me to climb out of it
Australia has become the first country to prescribe MDMA to treat PTSD and psilocybin to combat treatment-resistant depression.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.